EQS Newswire is a major provider of regulatory and corporate news. It mainly serves companies, investors and media worldwide. Through its services, EQS Newswire enables efficient and secure communication between companies and their stakeholders. Its main services include the distribution of ad hoc announcements, corporate news and the publication of financial reports that meet strict international standards.
Thu, 18.01.2024
COLTENE Holding AG, a leading international developer and manufacturer of dental consumables and small equipment, publishes key figures for the financial year 2023. Net sales are expected to amount to CHF 242.6 million. The operating result is anticipated to close with a margin of approximately 8%. Dominik Arnold took over the position of CEO of th...
The Board of Directors of the COLTENE group, a leading international developer and manufacturer of dental consumables and small equipment, has appointed Dominik Arnold (51) to become the new CEO of the COLTENE group as of 1 January 2024. Dominik Arnold succeeds Martin Schaufelberger (59) who will step down from operations at the end of the year.
...
COLTENE, a leading international developer and manufacturer of dental consumables and small equipment, achieved a pleasing business performance in the first half (H1) of 2023 despite a challenging business environment. Net sales were up 1.7% year-on-year, at constant exchange rates, outperforming the strong result of the same period a year earlier....
COLTENE Holding AG
/ Key word(s): Miscellaneous
Annual General Meeting – Shareholders approve all proposals of the Board of Directors
19.04.2023 / 18:45 CET/CEST
Media ReleaseAltstätten, 19 April 2023
COLTENE, a leading international developer and manufacturer of dental consumables and small equipment, announces tha...
COLTENE Holding AG
/ Key word(s): Miscellaneous
Annual General Meeting – Shareholders approve all proposals of the Board of Directors
19.04.2023 / 18:45 CET/CEST
Media ReleaseAltstätten, 19 April 2023
COLTENE, a leading international developer and manufacturer of dental consumables and small equipment, announces tha...
COLTENE achieved sales of CHF 267.1 million, down 4.3%.
Operating profit (EBIT) reached CHF 34.9 million (2021: CHF 43.8 million).
Operating profit margin 2022 was 13.1% (2021: 15.7%).
Net Income was CHF 26.0 million (2021: CHF 31.7 million).
The Board of Directors proposes a dividend of CHF 3.30 per share from capital contribution reserves to ...
COLTENE achieved sales of CHF 267.1 million, down 4.3%.
Operating profit (EBIT) reached CHF 34.9 million (2021: CHF 43.8 million).
Operating profit margin 2022 was 13.1% (2021: 15.7%).
Net Income was CHF 26.0 million (2021: CHF 31.7 million).
The Board of Directors proposes a dividend of CHF 3.30 per share from capital contribution reserves to ...
COLTENE achieved sales of CHF 267.1 million, down 4.3%.
Operating profit (EBIT) reached CHF 34.9 million (2021: CHF 43.8 million).
Operating profit margin 2022 was 13.1% (2021: 15.7%).
Net Income was CHF 26.0 million (2021: CHF 31.7 million).
The Board of Directors proposes a dividend of CHF 3.30 per share from capital contribution reserves to ...
COLTENE achieved sales of CHF 267.1 million, down 4.3%.
Operating profit (EBIT) reached CHF 34.9 million (2021: CHF 43.8 million).
Operating profit margin 2022 was 13.1% (2021: 15.7%).
Net Income was CHF 26.0 million (2021: CHF 31.7 million).
The Board of Directors proposes a dividend of CHF 3.30 per share from capital contribution reserves to ...
Ad hoc announcement pursuant to Art. 53 LR
COLTENE, a leading international developer and manufacturer of dental consumables and small equipment, announces its first key figures for the 2022 financial year. Compared to the previously anticipated sales at the level of the 2021 business year (CHF 279.2 million), the company is expected to achieve sal...
You have pressed the "". We would like to inform you that you are now leaving the information service of the portal site ayondo.com. You will be redirected to . After confirming the "Continue" button, you confirm that you have been informed of this. You also confirm that you are carrying out this process of your own free will and that it is not the result of any promotional activity or other influence. Continue to .